Skip to content

Effectiveness of Personalized Lifestyle Intervention using CGM in Patients with Diabetes: A Randomized Clinical Trial

Effectiveness of Personalized Lifestyle Intervention using CGM in Patients with Diabetes: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008872
Enrollment
102
Registered
2023-10-16
Start date
2023-06-12
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Control group: Standard care (Basic Education about Diabetes) Experimental Group1: Provision of CGM (three times at one-month intervals). Experimental Group 2: Group 2: Provision of C

Sponsors

Jeonbuk National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Adults aged 20 to 80 years. (2) Individuals diagnosed with type 2 diabetes for at least 6 months. (3) Individuals with HbA1C levels of 6.5% or higher. (4) Individuals with a smartphone. (5) Patients who have not previously used a continuous glucose monitoring (CGM) device. (6) Individuals who have a sufficient understanding of the research purpose and procedures, and voluntarily consent to participate in the clinical study.

Exclusion criteria

Exclusion criteria: (1) Individuals with a history of psychiatric disorders. (2) Individuals with serious comorbid conditions requiring treatment in addition to diabetes (e.g., diabetic nephropathy). (3) Individuals who have undergone surgery within the past year. (4) Individuals diagnosed with cancer within the past 5 years. (5) Individuals who have received organ transplantation. (6) Individuals who have received diabetes education counseling within the last 6 months. (7) Patients whose medication has been changed within the last 3 months.

Design outcomes

Primary

MeasureTime frame
HbA1C

Secondary

MeasureTime frame
indices of Continuous Glucose Monitoring (CGM), lifestyles and diet variables, steps, sleep pattern, Fasting blood sugar(FBS), HbA1C, Triglyceride, Total Cholesterol, High-density lipoprotein Cholesterol (HDL-C), Low-density lipoprotein cholesterol (LDL-C), Bloold Pressure, Inbody indices, Waist Circumference, Diabetes self-management behaviors, hypoglycemic fear, System Usability Scale (SUS), DM empowerment etcl.

Countries

Korea, Republic of

Contacts

Public ContactYoungran Yang

Jeonbuk National University

youngran13@jbnu.ac.kr+82-63-270-3116

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Jun 21, 2026